nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—NCOA3—breast cancer	0.304	0.672	CbGaD
Amsacrine—TOP2A—Idarubicin—breast cancer	0.105	0.334	CbGbCtD
Amsacrine—TOP2A—breast cancer	0.0883	0.195	CbGaD
Amsacrine—TOP2A—Mitoxantrone—breast cancer	0.0453	0.144	CbGbCtD
Amsacrine—TOP2A—Epirubicin—breast cancer	0.0367	0.116	CbGbCtD
Amsacrine—CYP2D6—breast cancer	0.0352	0.0777	CbGaD
Amsacrine—ABCB1—breast cancer	0.0251	0.0555	CbGaD
Amsacrine—TOP2A—Doxorubicin—breast cancer	0.0195	0.0618	CbGbCtD
Amsacrine—ABCB1—Toremifene—breast cancer	0.017	0.0539	CbGbCtD
Amsacrine—CYP2D6—Idarubicin—breast cancer	0.0133	0.0421	CbGbCtD
Amsacrine—ABCB1—Lapatinib—breast cancer	0.0124	0.0393	CbGbCtD
Amsacrine—ABCB1—Vinorelbine—breast cancer	0.00688	0.0218	CbGbCtD
Amsacrine—CYP2D6—Vinorelbine—breast cancer	0.00649	0.0206	CbGbCtD
Amsacrine—ABCB1—Tamoxifen—breast cancer	0.00621	0.0197	CbGbCtD
Amsacrine—ABCB1—Mitoxantrone—breast cancer	0.00606	0.0192	CbGbCtD
Amsacrine—CYP2D6—Tamoxifen—breast cancer	0.00585	0.0186	CbGbCtD
Amsacrine—ABCB1—Gemcitabine—breast cancer	0.00535	0.017	CbGbCtD
Amsacrine—ABCB1—Paclitaxel—breast cancer	0.00484	0.0153	CbGbCtD
Amsacrine—ABCB1—Irinotecan—breast cancer	0.00477	0.0151	CbGbCtD
Amsacrine—ABCB1—Vinblastine—breast cancer	0.00424	0.0134	CbGbCtD
Amsacrine—CYP2D6—Vinblastine—breast cancer	0.004	0.0127	CbGbCtD
Amsacrine—ABCB1—Docetaxel—breast cancer	0.0035	0.0111	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—breast cancer	0.00261	0.00826	CbGbCtD
Amsacrine—ABCB1—Methotrexate—breast cancer	0.00253	0.00801	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—breast cancer	0.00246	0.00779	CbGbCtD
Amsacrine—NCOA3—nipple—breast cancer	0.002	0.0875	CbGeAlD
Amsacrine—NCOA3—endometrium—breast cancer	0.0012	0.0529	CbGeAlD
Amsacrine—TOP2A—nipple—breast cancer	0.00117	0.0514	CbGeAlD
Amsacrine—NCOA3—uterus—breast cancer	0.00111	0.0487	CbGeAlD
Amsacrine—NCOA3—pituitary gland—breast cancer	0.00109	0.0478	CbGeAlD
Amsacrine—NCOA3—adipose tissue—breast cancer	0.00109	0.0476	CbGeAlD
Amsacrine—NCOA3—female reproductive system—breast cancer	0.000998	0.0438	CbGeAlD
Amsacrine—NCOA3—adrenal gland—breast cancer	0.000974	0.0427	CbGeAlD
Amsacrine—NCOA3—bone marrow—breast cancer	0.000942	0.0413	CbGeAlD
Amsacrine—NCOA3—Topotecan—Irinotecan—breast cancer	0.000913	0.327	CbGdCrCtD
Amsacrine—NCOA3—female gonad—breast cancer	0.000908	0.0398	CbGeAlD
Amsacrine—NCOA3—endocrine gland—breast cancer	0.000845	0.0371	CbGeAlD
Amsacrine—TOP2A—endometrium—breast cancer	0.000707	0.031	CbGeAlD
Amsacrine—KCNH2—nipple—breast cancer	0.000656	0.0288	CbGeAlD
Amsacrine—TOP2A—uterus—breast cancer	0.000651	0.0286	CbGeAlD
Amsacrine—TOP2A—adipose tissue—breast cancer	0.000637	0.0279	CbGeAlD
Amsacrine—NCOA3—lymph node—breast cancer	0.000584	0.0256	CbGeAlD
Amsacrine—TOP2A—adrenal gland—breast cancer	0.000571	0.0251	CbGeAlD
Amsacrine—TOP2A—bone marrow—breast cancer	0.000553	0.0243	CbGeAlD
Amsacrine—TOP2A—female gonad—breast cancer	0.000533	0.0234	CbGeAlD
Amsacrine—KCNH2—endometrium—breast cancer	0.000396	0.0174	CbGeAlD
Amsacrine—KCNH2—uterus—breast cancer	0.000365	0.016	CbGeAlD
Amsacrine—KCNH2—pituitary gland—breast cancer	0.000358	0.0157	CbGeAlD
Amsacrine—TOP2A—lymph node—breast cancer	0.000343	0.015	CbGeAlD
Amsacrine—KCNH2—female reproductive system—breast cancer	0.000328	0.0144	CbGeAlD
Amsacrine—KCNH2—adrenal gland—breast cancer	0.00032	0.014	CbGeAlD
Amsacrine—KCNH2—bone marrow—breast cancer	0.00031	0.0136	CbGeAlD
Amsacrine—KCNH2—female gonad—breast cancer	0.000299	0.0131	CbGeAlD
Amsacrine—KCNH2—endocrine gland—breast cancer	0.000278	0.0122	CbGeAlD
Amsacrine—ABCB1—embryo—breast cancer	0.000237	0.0104	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Epirubicin—breast cancer	0.000215	0.0769	CbGdCrCtD
Amsacrine—CYP2D6—female reproductive system—breast cancer	0.0002	0.00878	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—breast cancer	0.000199	0.0712	CbGdCrCtD
Amsacrine—ABCB1—epithelium—breast cancer	0.000194	0.0085	CbGeAlD
Amsacrine—KCNH2—lymph node—breast cancer	0.000192	0.00842	CbGeAlD
Amsacrine—CYP2D6—female gonad—breast cancer	0.000182	0.00799	CbGeAlD
Amsacrine—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.000176	0.0632	CbGdCrCtD
Amsacrine—ABCB1—endometrium—breast cancer	0.000174	0.00762	CbGeAlD
Amsacrine—TOP2A—Gefitinib—Lapatinib—breast cancer	0.000173	0.062	CbGdCrCtD
Amsacrine—CYP2D6—endocrine gland—breast cancer	0.000169	0.00743	CbGeAlD
Amsacrine—ABCB1—uterus—breast cancer	0.00016	0.00702	CbGeAlD
Amsacrine—ABCB1—pituitary gland—breast cancer	0.000157	0.0069	CbGeAlD
Amsacrine—ABCB1—adipose tissue—breast cancer	0.000157	0.00687	CbGeAlD
Amsacrine—ABCB1—female reproductive system—breast cancer	0.000144	0.00631	CbGeAlD
Amsacrine—ABCB1—adrenal gland—breast cancer	0.00014	0.00616	CbGeAlD
Amsacrine—ABCB1—bone marrow—breast cancer	0.000136	0.00596	CbGeAlD
Amsacrine—ABCB1—female gonad—breast cancer	0.000131	0.00575	CbGeAlD
Amsacrine—TOP2A—Topotecan—Irinotecan—breast cancer	0.000125	0.045	CbGdCrCtD
Amsacrine—ABCB1—endocrine gland—breast cancer	0.000122	0.00534	CbGeAlD
Amsacrine—TOP2A—Vindesine—Vinorelbine—breast cancer	0.000112	0.0402	CbGdCrCtD
Amsacrine—TOP2A—Vindesine—Vinblastine—breast cancer	8.97e-05	0.0321	CbGdCrCtD
Amsacrine—TOP2A—Paclitaxel—Docetaxel—breast cancer	8.8e-05	0.0315	CbGdCrCtD
Amsacrine—ABCB1—lymph node—breast cancer	8.42e-05	0.00369	CbGeAlD
Amsacrine—TOP2A—Daunorubicin—Idarubicin—breast cancer	6.42e-05	0.023	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Idarubicin—breast cancer	6.42e-05	0.023	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Idarubicin—breast cancer	6.42e-05	0.023	CbGdCrCtD
Amsacrine—TOP2A—Vincristine—Vinorelbine—breast cancer	6.05e-05	0.0217	CbGdCrCtD
Amsacrine—TOP2A—Vinorelbine—Vinblastine—breast cancer	5.66e-05	0.0203	CbGdCrCtD
Amsacrine—TOP2A—Vinblastine—Vinorelbine—breast cancer	4.87e-05	0.0174	CbGdCrCtD
Amsacrine—TOP2A—Vincristine—Vinblastine—breast cancer	4.84e-05	0.0173	CbGdCrCtD
Amsacrine—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	4.07e-05	0.0146	CbGdCrCtD
Amsacrine—TOP2A—Cytarabine—Gemcitabine—breast cancer	3.18e-05	0.0114	CbGdCrCtD
Amsacrine—Decreased appetite—Paclitaxel—breast cancer	3.12e-05	0.000238	CcSEcCtD
Amsacrine—Hypersensitivity—Fluorouracil—breast cancer	3.11e-05	0.000237	CcSEcCtD
Amsacrine—Haemoglobin—Methotrexate—breast cancer	3.1e-05	0.000236	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Paclitaxel—breast cancer	3.1e-05	0.000236	CcSEcCtD
Amsacrine—Fatigue—Paclitaxel—breast cancer	3.1e-05	0.000236	CcSEcCtD
Amsacrine—Haemorrhage—Methotrexate—breast cancer	3.09e-05	0.000235	CcSEcCtD
Amsacrine—Hepatitis—Methotrexate—breast cancer	3.09e-05	0.000235	CcSEcCtD
Amsacrine—Asthenia—Gemcitabine—breast cancer	3.08e-05	0.000234	CcSEcCtD
Amsacrine—Pain—Paclitaxel—breast cancer	3.07e-05	0.000234	CcSEcCtD
Amsacrine—Haematuria—Epirubicin—breast cancer	3.07e-05	0.000234	CcSEcCtD
Amsacrine—Confusional state—Docetaxel—breast cancer	3.07e-05	0.000234	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	3.05e-05	0.000233	CcSEcCtD
Amsacrine—Urinary tract disorder—Methotrexate—breast cancer	3.05e-05	0.000232	CcSEcCtD
Amsacrine—Hepatobiliary disease—Epirubicin—breast cancer	3.04e-05	0.000232	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—breast cancer	3.04e-05	0.000232	CcSEcCtD
Amsacrine—Nausea—Thiotepa—breast cancer	3.03e-05	0.000231	CcSEcCtD
Amsacrine—Urethral disorder—Methotrexate—breast cancer	3.03e-05	0.000231	CcSEcCtD
Amsacrine—Infection—Docetaxel—breast cancer	3.02e-05	0.00023	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—breast cancer	3.02e-05	0.00023	CcSEcCtD
Amsacrine—Diarrhoea—Irinotecan—breast cancer	3.01e-05	0.000229	CcSEcCtD
Amsacrine—Diarrhoea—Mitoxantrone—breast cancer	3.01e-05	0.000229	CcSEcCtD
Amsacrine—Agranulocytosis—Epirubicin—breast cancer	3e-05	0.000229	CcSEcCtD
Amsacrine—Thrombocytopenia—Docetaxel—breast cancer	2.98e-05	0.000227	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—breast cancer	2.98e-05	0.000227	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—breast cancer	2.98e-05	0.000227	CcSEcCtD
Amsacrine—Confusional state—Capecitabine—breast cancer	2.97e-05	0.000226	CcSEcCtD
Amsacrine—Tachycardia—Docetaxel—breast cancer	2.97e-05	0.000226	CcSEcCtD
Amsacrine—Feeling abnormal—Paclitaxel—breast cancer	2.96e-05	0.000225	CcSEcCtD
Amsacrine—Skin disorder—Docetaxel—breast cancer	2.96e-05	0.000225	CcSEcCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—breast cancer	2.95e-05	0.0106	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—breast cancer	2.95e-05	0.0106	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—breast cancer	2.95e-05	0.0106	CbGdCrCtD
Amsacrine—Bradycardia—Epirubicin—breast cancer	2.94e-05	0.000224	CcSEcCtD
Amsacrine—Gastrointestinal pain—Paclitaxel—breast cancer	2.94e-05	0.000224	CcSEcCtD
Amsacrine—Diarrhoea—Gemcitabine—breast cancer	2.93e-05	0.000224	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—breast cancer	2.93e-05	0.000223	CcSEcCtD
Amsacrine—Infection—Capecitabine—breast cancer	2.93e-05	0.000223	CcSEcCtD
Amsacrine—Dizziness—Irinotecan—breast cancer	2.91e-05	0.000222	CcSEcCtD
Amsacrine—Haemoglobin—Epirubicin—breast cancer	2.9e-05	0.000221	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—breast cancer	2.9e-05	0.000221	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—breast cancer	2.9e-05	0.000221	CcSEcCtD
Amsacrine—Anorexia—Docetaxel—breast cancer	2.9e-05	0.000221	CcSEcCtD
Amsacrine—Haemorrhage—Epirubicin—breast cancer	2.89e-05	0.00022	CcSEcCtD
Amsacrine—Hepatitis—Epirubicin—breast cancer	2.89e-05	0.00022	CcSEcCtD
Amsacrine—Diarrhoea—Fluorouracil—breast cancer	2.89e-05	0.00022	CcSEcCtD
Amsacrine—Thrombocytopenia—Capecitabine—breast cancer	2.89e-05	0.00022	CcSEcCtD
Amsacrine—Tachycardia—Capecitabine—breast cancer	2.88e-05	0.000219	CcSEcCtD
Amsacrine—Hypoaesthesia—Epirubicin—breast cancer	2.88e-05	0.000219	CcSEcCtD
Amsacrine—Cardiac disorder—Methotrexate—breast cancer	2.87e-05	0.000218	CcSEcCtD
Amsacrine—Skin disorder—Capecitabine—breast cancer	2.86e-05	0.000218	CcSEcCtD
Amsacrine—Urinary tract disorder—Epirubicin—breast cancer	2.85e-05	0.000217	CcSEcCtD
Amsacrine—Urticaria—Paclitaxel—breast cancer	2.85e-05	0.000217	CcSEcCtD
Amsacrine—Hypotension—Docetaxel—breast cancer	2.84e-05	0.000217	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—breast cancer	2.84e-05	0.000216	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—breast cancer	2.84e-05	0.000216	CcSEcCtD
Amsacrine—Body temperature increased—Paclitaxel—breast cancer	2.84e-05	0.000216	CcSEcCtD
Amsacrine—Abdominal pain—Paclitaxel—breast cancer	2.84e-05	0.000216	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—breast cancer	2.83e-05	0.000216	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—breast cancer	2.82e-05	0.000215	CcSEcCtD
Amsacrine—Anorexia—Capecitabine—breast cancer	2.81e-05	0.000214	CcSEcCtD
Amsacrine—Angiopathy—Methotrexate—breast cancer	2.8e-05	0.000213	CcSEcCtD
Amsacrine—Vomiting—Mitoxantrone—breast cancer	2.8e-05	0.000213	CcSEcCtD
Amsacrine—Vomiting—Irinotecan—breast cancer	2.8e-05	0.000213	CcSEcCtD
Amsacrine—Dizziness—Fluorouracil—breast cancer	2.79e-05	0.000212	CcSEcCtD
Amsacrine—Mediastinal disorder—Methotrexate—breast cancer	2.78e-05	0.000212	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—breast cancer	2.78e-05	0.000212	CcSEcCtD
Amsacrine—Rash—Mitoxantrone—breast cancer	2.78e-05	0.000211	CcSEcCtD
Amsacrine—Rash—Irinotecan—breast cancer	2.78e-05	0.000211	CcSEcCtD
Amsacrine—Dermatitis—Mitoxantrone—breast cancer	2.77e-05	0.000211	CcSEcCtD
Amsacrine—Dermatitis—Irinotecan—breast cancer	2.77e-05	0.000211	CcSEcCtD
Amsacrine—Headache—Irinotecan—breast cancer	2.76e-05	0.00021	CcSEcCtD
Amsacrine—Headache—Mitoxantrone—breast cancer	2.76e-05	0.00021	CcSEcCtD
Amsacrine—Hypotension—Capecitabine—breast cancer	2.75e-05	0.00021	CcSEcCtD
Amsacrine—Paraesthesia—Docetaxel—breast cancer	2.73e-05	0.000208	CcSEcCtD
Amsacrine—Alopecia—Methotrexate—breast cancer	2.73e-05	0.000208	CcSEcCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—breast cancer	2.73e-05	0.00978	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—breast cancer	2.73e-05	0.00978	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—breast cancer	2.73e-05	0.00978	CbGdCrCtD
Amsacrine—Vomiting—Gemcitabine—breast cancer	2.73e-05	0.000208	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—breast cancer	2.72e-05	0.000207	CcSEcCtD
Amsacrine—Dyspnoea—Docetaxel—breast cancer	2.71e-05	0.000207	CcSEcCtD
Amsacrine—Mental disorder—Methotrexate—breast cancer	2.71e-05	0.000206	CcSEcCtD
Amsacrine—Rash—Gemcitabine—breast cancer	2.7e-05	0.000206	CcSEcCtD
Amsacrine—Dermatitis—Gemcitabine—breast cancer	2.7e-05	0.000206	CcSEcCtD
Amsacrine—Malnutrition—Methotrexate—breast cancer	2.69e-05	0.000205	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—breast cancer	2.69e-05	0.000205	CcSEcCtD
Amsacrine—Headache—Gemcitabine—breast cancer	2.69e-05	0.000205	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—breast cancer	2.68e-05	0.000204	CcSEcCtD
Amsacrine—Vomiting—Fluorouracil—breast cancer	2.68e-05	0.000204	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—breast cancer	2.67e-05	0.000204	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—breast cancer	2.67e-05	0.000204	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—breast cancer	2.66e-05	0.000203	CcSEcCtD
Amsacrine—Rash—Fluorouracil—breast cancer	2.66e-05	0.000203	CcSEcCtD
Amsacrine—Dermatitis—Fluorouracil—breast cancer	2.66e-05	0.000202	CcSEcCtD
Amsacrine—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	2.66e-05	0.00952	CbGdCrCtD
Amsacrine—Paraesthesia—Capecitabine—breast cancer	2.65e-05	0.000202	CcSEcCtD
Amsacrine—Decreased appetite—Docetaxel—breast cancer	2.65e-05	0.000202	CcSEcCtD
Amsacrine—Hypersensitivity—Paclitaxel—breast cancer	2.65e-05	0.000202	CcSEcCtD
Amsacrine—Headache—Fluorouracil—breast cancer	2.64e-05	0.000201	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—breast cancer	2.64e-05	0.000201	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Docetaxel—breast cancer	2.63e-05	0.0002	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—breast cancer	2.63e-05	0.0002	CcSEcCtD
Amsacrine—Dyspnoea—Capecitabine—breast cancer	2.63e-05	0.0002	CcSEcCtD
Amsacrine—Fatigue—Docetaxel—breast cancer	2.62e-05	0.0002	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—breast cancer	2.62e-05	0.0002	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—breast cancer	2.62e-05	0.0002	CcSEcCtD
Amsacrine—Nausea—Mitoxantrone—breast cancer	2.62e-05	0.000199	CcSEcCtD
Amsacrine—Nausea—Irinotecan—breast cancer	2.62e-05	0.000199	CcSEcCtD
Amsacrine—Mediastinal disorder—Epirubicin—breast cancer	2.6e-05	0.000198	CcSEcCtD
Amsacrine—Pain—Docetaxel—breast cancer	2.6e-05	0.000198	CcSEcCtD
Amsacrine—Arrhythmia—Epirubicin—breast cancer	2.58e-05	0.000197	CcSEcCtD
Amsacrine—Asthenia—Paclitaxel—breast cancer	2.58e-05	0.000196	CcSEcCtD
Amsacrine—Decreased appetite—Capecitabine—breast cancer	2.56e-05	0.000195	CcSEcCtD
Amsacrine—Alopecia—Epirubicin—breast cancer	2.55e-05	0.000195	CcSEcCtD
Amsacrine—Nausea—Gemcitabine—breast cancer	2.55e-05	0.000194	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Capecitabine—breast cancer	2.54e-05	0.000194	CcSEcCtD
Amsacrine—Fatigue—Capecitabine—breast cancer	2.54e-05	0.000194	CcSEcCtD
Amsacrine—Vision blurred—Methotrexate—breast cancer	2.53e-05	0.000193	CcSEcCtD
Amsacrine—Mental disorder—Epirubicin—breast cancer	2.53e-05	0.000193	CcSEcCtD
Amsacrine—Pain—Capecitabine—breast cancer	2.52e-05	0.000192	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—breast cancer	2.52e-05	0.000192	CcSEcCtD
Amsacrine—Feeling abnormal—Docetaxel—breast cancer	2.51e-05	0.000191	CcSEcCtD
Amsacrine—Nausea—Fluorouracil—breast cancer	2.5e-05	0.000191	CcSEcCtD
Amsacrine—Gastrointestinal pain—Docetaxel—breast cancer	2.49e-05	0.00019	CcSEcCtD
Amsacrine—Anaemia—Methotrexate—breast cancer	2.48e-05	0.000189	CcSEcCtD
Amsacrine—Cardiac disorder—Doxorubicin—breast cancer	2.48e-05	0.000189	CcSEcCtD
Amsacrine—Diarrhoea—Paclitaxel—breast cancer	2.46e-05	0.000187	CcSEcCtD
Amsacrine—Feeling abnormal—Capecitabine—breast cancer	2.43e-05	0.000185	CcSEcCtD
Amsacrine—Angiopathy—Doxorubicin—breast cancer	2.43e-05	0.000185	CcSEcCtD
Amsacrine—Gastrointestinal pain—Capecitabine—breast cancer	2.41e-05	0.000184	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—breast cancer	2.41e-05	0.000184	CcSEcCtD
Amsacrine—Body temperature increased—Docetaxel—breast cancer	2.41e-05	0.000183	CcSEcCtD
Amsacrine—Abdominal pain—Docetaxel—breast cancer	2.41e-05	0.000183	CcSEcCtD
Amsacrine—Leukopenia—Methotrexate—breast cancer	2.41e-05	0.000183	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—breast cancer	2.39e-05	0.000182	CcSEcCtD
Amsacrine—Dizziness—Paclitaxel—breast cancer	2.37e-05	0.000181	CcSEcCtD
Amsacrine—Vision blurred—Epirubicin—breast cancer	2.37e-05	0.000181	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—breast cancer	2.36e-05	0.00018	CcSEcCtD
Amsacrine—Mental disorder—Doxorubicin—breast cancer	2.34e-05	0.000178	CcSEcCtD
Amsacrine—Urticaria—Capecitabine—breast cancer	2.34e-05	0.000178	CcSEcCtD
Amsacrine—Abdominal pain—Capecitabine—breast cancer	2.33e-05	0.000177	CcSEcCtD
Amsacrine—Body temperature increased—Capecitabine—breast cancer	2.33e-05	0.000177	CcSEcCtD
Amsacrine—Convulsion—Methotrexate—breast cancer	2.33e-05	0.000177	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—breast cancer	2.33e-05	0.000177	CcSEcCtD
Amsacrine—Anaemia—Epirubicin—breast cancer	2.33e-05	0.000177	CcSEcCtD
Amsacrine—Vomiting—Paclitaxel—breast cancer	2.28e-05	0.000174	CcSEcCtD
Amsacrine—TOP2A—Azacitidine—Gemcitabine—breast cancer	2.28e-05	0.00817	CbGdCrCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.27e-05	0.000173	CcSEcCtD
Amsacrine—Rash—Paclitaxel—breast cancer	2.26e-05	0.000172	CcSEcCtD
Amsacrine—Dermatitis—Paclitaxel—breast cancer	2.26e-05	0.000172	CcSEcCtD
Amsacrine—Leukopenia—Epirubicin—breast cancer	2.25e-05	0.000172	CcSEcCtD
Amsacrine—Headache—Paclitaxel—breast cancer	2.25e-05	0.000171	CcSEcCtD
Amsacrine—Hypersensitivity—Docetaxel—breast cancer	2.24e-05	0.000171	CcSEcCtD
Amsacrine—Confusional state—Methotrexate—breast cancer	2.21e-05	0.000169	CcSEcCtD
Amsacrine—Vision blurred—Doxorubicin—breast cancer	2.19e-05	0.000167	CcSEcCtD
Amsacrine—Asthenia—Docetaxel—breast cancer	2.18e-05	0.000166	CcSEcCtD
Amsacrine—Convulsion—Epirubicin—breast cancer	2.18e-05	0.000166	CcSEcCtD
Amsacrine—Infection—Methotrexate—breast cancer	2.18e-05	0.000166	CcSEcCtD
Amsacrine—Hypersensitivity—Capecitabine—breast cancer	2.17e-05	0.000165	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—breast cancer	2.15e-05	0.000164	CcSEcCtD
Amsacrine—Thrombocytopenia—Methotrexate—breast cancer	2.15e-05	0.000164	CcSEcCtD
Amsacrine—Nausea—Paclitaxel—breast cancer	2.13e-05	0.000162	CcSEcCtD
Amsacrine—Skin disorder—Methotrexate—breast cancer	2.13e-05	0.000162	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.13e-05	0.000162	CcSEcCtD
Amsacrine—Asthenia—Capecitabine—breast cancer	2.11e-05	0.000161	CcSEcCtD
Amsacrine—Anorexia—Methotrexate—breast cancer	2.09e-05	0.000159	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—breast cancer	2.08e-05	0.000159	CcSEcCtD
Amsacrine—Diarrhoea—Docetaxel—breast cancer	2.08e-05	0.000159	CcSEcCtD
Amsacrine—Confusional state—Epirubicin—breast cancer	2.07e-05	0.000158	CcSEcCtD
Amsacrine—Hypotension—Methotrexate—breast cancer	2.05e-05	0.000156	CcSEcCtD
Amsacrine—Infection—Epirubicin—breast cancer	2.04e-05	0.000155	CcSEcCtD
Amsacrine—Convulsion—Doxorubicin—breast cancer	2.02e-05	0.000154	CcSEcCtD
Amsacrine—Diarrhoea—Capecitabine—breast cancer	2.02e-05	0.000154	CcSEcCtD
Amsacrine—Dizziness—Docetaxel—breast cancer	2.01e-05	0.000153	CcSEcCtD
Amsacrine—Thrombocytopenia—Epirubicin—breast cancer	2.01e-05	0.000153	CcSEcCtD
Amsacrine—Tachycardia—Epirubicin—breast cancer	2e-05	0.000153	CcSEcCtD
Amsacrine—Skin disorder—Epirubicin—breast cancer	1.99e-05	0.000152	CcSEcCtD
Amsacrine—Paraesthesia—Methotrexate—breast cancer	1.97e-05	0.00015	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.97e-05	0.00015	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—breast cancer	1.96e-05	0.000149	CcSEcCtD
Amsacrine—Dyspnoea—Methotrexate—breast cancer	1.96e-05	0.000149	CcSEcCtD
Amsacrine—Dizziness—Capecitabine—breast cancer	1.95e-05	0.000148	CcSEcCtD
Amsacrine—Vomiting—Docetaxel—breast cancer	1.94e-05	0.000147	CcSEcCtD
Amsacrine—Rash—Docetaxel—breast cancer	1.92e-05	0.000146	CcSEcCtD
Amsacrine—Hypotension—Epirubicin—breast cancer	1.92e-05	0.000146	CcSEcCtD
Amsacrine—Dermatitis—Docetaxel—breast cancer	1.92e-05	0.000146	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—breast cancer	1.92e-05	0.000146	CcSEcCtD
Amsacrine—Decreased appetite—Methotrexate—breast cancer	1.91e-05	0.000145	CcSEcCtD
Amsacrine—Headache—Docetaxel—breast cancer	1.91e-05	0.000145	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Methotrexate—breast cancer	1.89e-05	0.000144	CcSEcCtD
Amsacrine—Fatigue—Methotrexate—breast cancer	1.89e-05	0.000144	CcSEcCtD
Amsacrine—Infection—Doxorubicin—breast cancer	1.89e-05	0.000144	CcSEcCtD
Amsacrine—Pain—Methotrexate—breast cancer	1.88e-05	0.000143	CcSEcCtD
Amsacrine—Vomiting—Capecitabine—breast cancer	1.87e-05	0.000143	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—breast cancer	1.86e-05	0.000142	CcSEcCtD
Amsacrine—Rash—Capecitabine—breast cancer	1.86e-05	0.000142	CcSEcCtD
Amsacrine—Dermatitis—Capecitabine—breast cancer	1.86e-05	0.000141	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—breast cancer	1.85e-05	0.000141	CcSEcCtD
Amsacrine—Headache—Capecitabine—breast cancer	1.85e-05	0.000141	CcSEcCtD
Amsacrine—Skin disorder—Doxorubicin—breast cancer	1.85e-05	0.000141	CcSEcCtD
Amsacrine—Paraesthesia—Epirubicin—breast cancer	1.84e-05	0.00014	CcSEcCtD
Amsacrine—Dyspnoea—Epirubicin—breast cancer	1.83e-05	0.000139	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—breast cancer	1.81e-05	0.000138	CcSEcCtD
Amsacrine—Nausea—Docetaxel—breast cancer	1.81e-05	0.000138	CcSEcCtD
Amsacrine—Feeling abnormal—Methotrexate—breast cancer	1.81e-05	0.000138	CcSEcCtD
Amsacrine—Gastrointestinal pain—Methotrexate—breast cancer	1.79e-05	0.000137	CcSEcCtD
Amsacrine—Decreased appetite—Epirubicin—breast cancer	1.78e-05	0.000136	CcSEcCtD
Amsacrine—Hypotension—Doxorubicin—breast cancer	1.78e-05	0.000135	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Epirubicin—breast cancer	1.77e-05	0.000135	CcSEcCtD
Amsacrine—Fatigue—Epirubicin—breast cancer	1.77e-05	0.000135	CcSEcCtD
Amsacrine—Pain—Epirubicin—breast cancer	1.76e-05	0.000134	CcSEcCtD
Amsacrine—Nausea—Capecitabine—breast cancer	1.75e-05	0.000133	CcSEcCtD
Amsacrine—Urticaria—Methotrexate—breast cancer	1.74e-05	0.000133	CcSEcCtD
Amsacrine—Abdominal pain—Methotrexate—breast cancer	1.73e-05	0.000132	CcSEcCtD
Amsacrine—Body temperature increased—Methotrexate—breast cancer	1.73e-05	0.000132	CcSEcCtD
Amsacrine—Paraesthesia—Doxorubicin—breast cancer	1.71e-05	0.00013	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—breast cancer	1.69e-05	0.000129	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—breast cancer	1.69e-05	0.000129	CcSEcCtD
Amsacrine—Gastrointestinal pain—Epirubicin—breast cancer	1.68e-05	0.000128	CcSEcCtD
Amsacrine—Decreased appetite—Doxorubicin—breast cancer	1.65e-05	0.000126	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.64e-05	0.000125	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—breast cancer	1.64e-05	0.000125	CcSEcCtD
Amsacrine—Urticaria—Epirubicin—breast cancer	1.63e-05	0.000124	CcSEcCtD
Amsacrine—Pain—Doxorubicin—breast cancer	1.62e-05	0.000124	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—breast cancer	1.62e-05	0.000124	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—breast cancer	1.62e-05	0.000124	CcSEcCtD
Amsacrine—Hypersensitivity—Methotrexate—breast cancer	1.62e-05	0.000123	CcSEcCtD
Amsacrine—Asthenia—Methotrexate—breast cancer	1.57e-05	0.00012	CcSEcCtD
Amsacrine—Feeling abnormal—Doxorubicin—breast cancer	1.57e-05	0.000119	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—breast cancer	1.55e-05	0.000118	CcSEcCtD
Amsacrine—Hypersensitivity—Epirubicin—breast cancer	1.51e-05	0.000115	CcSEcCtD
Amsacrine—Urticaria—Doxorubicin—breast cancer	1.51e-05	0.000115	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—breast cancer	1.5e-05	0.000114	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—breast cancer	1.5e-05	0.000114	CcSEcCtD
Amsacrine—Diarrhoea—Methotrexate—breast cancer	1.5e-05	0.000114	CcSEcCtD
Amsacrine—Asthenia—Epirubicin—breast cancer	1.47e-05	0.000112	CcSEcCtD
Amsacrine—Dizziness—Methotrexate—breast cancer	1.45e-05	0.000111	CcSEcCtD
Amsacrine—Diarrhoea—Epirubicin—breast cancer	1.4e-05	0.000107	CcSEcCtD
Amsacrine—Hypersensitivity—Doxorubicin—breast cancer	1.4e-05	0.000107	CcSEcCtD
Amsacrine—Vomiting—Methotrexate—breast cancer	1.39e-05	0.000106	CcSEcCtD
Amsacrine—Rash—Methotrexate—breast cancer	1.38e-05	0.000105	CcSEcCtD
Amsacrine—Dermatitis—Methotrexate—breast cancer	1.38e-05	0.000105	CcSEcCtD
Amsacrine—Headache—Methotrexate—breast cancer	1.37e-05	0.000105	CcSEcCtD
Amsacrine—Asthenia—Doxorubicin—breast cancer	1.36e-05	0.000104	CcSEcCtD
Amsacrine—Dizziness—Epirubicin—breast cancer	1.36e-05	0.000103	CcSEcCtD
Amsacrine—Vomiting—Epirubicin—breast cancer	1.31e-05	9.94e-05	CcSEcCtD
Amsacrine—Nausea—Methotrexate—breast cancer	1.3e-05	9.93e-05	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—breast cancer	1.3e-05	9.9e-05	CcSEcCtD
Amsacrine—Rash—Epirubicin—breast cancer	1.29e-05	9.86e-05	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—breast cancer	1.29e-05	9.85e-05	CcSEcCtD
Amsacrine—Headache—Epirubicin—breast cancer	1.29e-05	9.8e-05	CcSEcCtD
Amsacrine—Dizziness—Doxorubicin—breast cancer	1.26e-05	9.57e-05	CcSEcCtD
Amsacrine—Nausea—Epirubicin—breast cancer	1.22e-05	9.29e-05	CcSEcCtD
Amsacrine—Vomiting—Doxorubicin—breast cancer	1.21e-05	9.2e-05	CcSEcCtD
Amsacrine—Rash—Doxorubicin—breast cancer	1.2e-05	9.12e-05	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—breast cancer	1.2e-05	9.12e-05	CcSEcCtD
Amsacrine—Headache—Doxorubicin—breast cancer	1.19e-05	9.07e-05	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	1.16e-05	0.000155	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—breast cancer	1.16e-05	0.000155	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCC1—breast cancer	1.15e-05	0.000153	CbGpPWpGaD
Amsacrine—Nausea—Doxorubicin—breast cancer	1.13e-05	8.6e-05	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—AKT1—breast cancer	1.11e-05	0.000148	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—RB1—breast cancer	1.09e-05	0.000146	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—breast cancer	1.09e-05	0.000146	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—breast cancer	1.09e-05	0.000145	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.04e-05	0.000139	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—breast cancer	1.04e-05	0.000138	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CD—breast cancer	1.02e-05	0.000136	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—breast cancer	1.01e-05	0.000135	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALB—breast cancer	1.01e-05	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SYNJ2—breast cancer	1.01e-05	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—breast cancer	1e-05	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TUBB3—breast cancer	9.74e-06	0.00013	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NOS3—breast cancer	9.62e-06	0.000128	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—breast cancer	9.6e-06	0.000128	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	9.56e-06	0.000128	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	9.52e-06	0.000127	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1B—breast cancer	9.51e-06	0.000127	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SYNJ2—breast cancer	9.47e-06	0.000126	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—breast cancer	9.35e-06	0.000125	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NDUFS3—breast cancer	9.34e-06	0.000125	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—breast cancer	9.32e-06	0.000124	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	9.29e-06	0.000124	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—breast cancer	9.08e-06	0.000121	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	9e-06	0.00012	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	8.9e-06	0.000119	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CB—breast cancer	8.88e-06	0.000119	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NDUFS3—breast cancer	8.81e-06	0.000118	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—breast cancer	8.8e-06	0.000117	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CHST9—breast cancer	8.79e-06	0.000117	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1A—breast cancer	8.78e-06	0.000117	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1B—breast cancer	8.51e-06	0.000114	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—breast cancer	8.42e-06	0.000112	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	8.38e-06	0.000112	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COX11—breast cancer	8.33e-06	0.000111	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CHST9—breast cancer	8.28e-06	0.00011	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	8.24e-06	0.00011	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—breast cancer	8.12e-06	0.000108	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	8.11e-06	0.000108	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	8.03e-06	0.000107	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	7.94e-06	0.000106	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1A—breast cancer	7.85e-06	0.000105	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COX11—breast cancer	7.85e-06	0.000105	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—breast cancer	7.68e-06	0.000102	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CDA—breast cancer	7.62e-06	0.000102	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SHMT1—breast cancer	7.62e-06	0.000102	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MAPK3—breast cancer	7.48e-06	9.99e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A5—breast cancer	7.33e-06	9.79e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLCO1B1—breast cancer	7.33e-06	9.79e-05	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—breast cancer	7.28e-06	9.72e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	7.19e-06	9.6e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CDA—breast cancer	7.18e-06	9.58e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SHMT1—breast cancer	7.18e-06	9.58e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	7.09e-06	9.46e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APRT—breast cancer	7.08e-06	9.45e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	7.08e-06	9.45e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	7.06e-06	9.43e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	6.99e-06	9.33e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A5—breast cancer	6.91e-06	9.22e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLCO1B1—breast cancer	6.91e-06	9.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	6.83e-06	9.12e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	6.81e-06	9.09e-05	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MAPK3—breast cancer	6.69e-06	8.93e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APRT—breast cancer	6.67e-06	8.91e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ANGPTL4—breast cancer	6.66e-06	8.89e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ESRRA—breast cancer	6.66e-06	8.89e-05	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—breast cancer	6.51e-06	8.69e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.5e-06	8.68e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	6.47e-06	8.64e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	6.34e-06	8.46e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HADHB—breast cancer	6.31e-06	8.42e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPI—breast cancer	6.31e-06	8.42e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.28e-06	8.38e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ESRRA—breast cancer	6.27e-06	8.37e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ANGPTL4—breast cancer	6.27e-06	8.37e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	6.17e-06	8.24e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	6.16e-06	8.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	6.11e-06	8.16e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDH1A1—breast cancer	6.02e-06	8.04e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDH7A1—breast cancer	6.02e-06	8.04e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	5.97e-06	7.97e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	5.96e-06	7.95e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPI—breast cancer	5.95e-06	7.94e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HADHB—breast cancer	5.95e-06	7.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	5.83e-06	7.78e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FHL2—breast cancer	5.77e-06	7.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PHGDH—breast cancer	5.77e-06	7.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NME1—breast cancer	5.77e-06	7.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ADSL—breast cancer	5.77e-06	7.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UMPS—breast cancer	5.77e-06	7.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	5.74e-06	7.66e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDH7A1—breast cancer	5.67e-06	7.57e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDH1A1—breast cancer	5.67e-06	7.57e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BRIP1—breast cancer	5.66e-06	7.56e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LDHB—breast cancer	5.66e-06	7.56e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HPSE—breast cancer	5.66e-06	7.56e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	5.6e-06	7.47e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	5.53e-06	7.37e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FHL2—breast cancer	5.44e-06	7.26e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UMPS—breast cancer	5.44e-06	7.26e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NME1—breast cancer	5.44e-06	7.26e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PHGDH—breast cancer	5.44e-06	7.26e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ADSL—breast cancer	5.44e-06	7.26e-05	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—breast cancer	5.41e-06	7.23e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	5.38e-06	7.18e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMMR—breast cancer	5.37e-06	7.16e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA3—breast cancer	5.37e-06	7.16e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCC1—breast cancer	5.37e-06	7.16e-05	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—breast cancer	5.35e-06	7.13e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HPSE—breast cancer	5.33e-06	7.12e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BRIP1—breast cancer	5.33e-06	7.12e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LDHB—breast cancer	5.33e-06	7.12e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARGC1B—breast cancer	5.2e-06	6.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	5.16e-06	6.89e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	5.09e-06	6.79e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCC1—breast cancer	5.06e-06	6.75e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA3—breast cancer	5.06e-06	6.75e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMMR—breast cancer	5.06e-06	6.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	4.95e-06	6.61e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	4.94e-06	6.59e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CA9—breast cancer	4.91e-06	6.55e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA4—breast cancer	4.91e-06	6.55e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARGC1B—breast cancer	4.9e-06	6.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	4.84e-06	6.46e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA2—breast cancer	4.78e-06	6.38e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX2—breast cancer	4.78e-06	6.38e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SULT1A1—breast cancer	4.72e-06	6.31e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX4—breast cancer	4.72e-06	6.31e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA4—breast cancer	4.63e-06	6.17e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CA9—breast cancer	4.63e-06	6.17e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—IDH1—breast cancer	4.62e-06	6.16e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA1—breast cancer	4.62e-06	6.16e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	4.61e-06	6.16e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	4.58e-06	6.11e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAT2—breast cancer	4.56e-06	6.09e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA2—breast cancer	4.51e-06	6.02e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX2—breast cancer	4.51e-06	6.02e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SULT1A1—breast cancer	4.45e-06	5.94e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX4—breast cancer	4.45e-06	5.94e-05	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—breast cancer	4.42e-06	5.9e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA1—breast cancer	4.35e-06	5.8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—IDH1—breast cancer	4.35e-06	5.8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAT2—breast cancer	4.3e-06	5.74e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	4.2e-06	5.61e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.07e-06	5.43e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MED12—breast cancer	4e-06	5.34e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—DPYD—breast cancer	4e-06	5.34e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDOA—breast cancer	3.94e-06	5.26e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA3—breast cancer	3.82e-06	5.1e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A2—breast cancer	3.8e-06	5.07e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—DPYD—breast cancer	3.77e-06	5.03e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MED12—breast cancer	3.77e-06	5.03e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTR—breast cancer	3.72e-06	4.96e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCG2—breast cancer	3.72e-06	4.96e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CPT1A—breast cancer	3.72e-06	4.96e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDOA—breast cancer	3.71e-06	4.95e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HPGDS—breast cancer	3.65e-06	4.87e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HBA1—breast cancer	3.63e-06	4.84e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA3—breast cancer	3.6e-06	4.81e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A2—breast cancer	3.58e-06	4.78e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACHE—breast cancer	3.54e-06	4.72e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTT1—breast cancer	3.54e-06	4.72e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTR—breast cancer	3.51e-06	4.68e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CPT1A—breast cancer	3.51e-06	4.68e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCG2—breast cancer	3.51e-06	4.68e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HPGDS—breast cancer	3.44e-06	4.59e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.43e-06	4.58e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HBA1—breast cancer	3.42e-06	4.56e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP17A1—breast cancer	3.35e-06	4.47e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACHE—breast cancer	3.33e-06	4.45e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTT1—breast cancer	3.33e-06	4.45e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS1—breast cancer	3.32e-06	4.42e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ENO1—breast cancer	3.32e-06	4.42e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2D6—breast cancer	3.25e-06	4.34e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA2—breast cancer	3.19e-06	4.26e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP17A1—breast cancer	3.16e-06	4.21e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ENO1—breast cancer	3.12e-06	4.17e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS1—breast cancer	3.12e-06	4.17e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.1e-06	4.14e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FASN—breast cancer	3.1e-06	4.13e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—BCHE—breast cancer	3.08e-06	4.11e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A5—breast cancer	3.04e-06	4.06e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA2—breast cancer	3.01e-06	4.01e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NQO1—breast cancer	2.94e-06	3.92e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC2A1—breast cancer	2.94e-06	3.92e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FASN—breast cancer	2.92e-06	3.89e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—BCHE—breast cancer	2.9e-06	3.88e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A5—breast cancer	2.87e-06	3.83e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP3A4—breast cancer	2.87e-06	3.83e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1B1—breast cancer	2.82e-06	3.76e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.8e-06	3.74e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC2A1—breast cancer	2.77e-06	3.7e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NQO1—breast cancer	2.77e-06	3.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSP90AA1—breast cancer	2.76e-06	3.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP3A4—breast cancer	2.7e-06	3.61e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA1—breast cancer	2.69e-06	3.59e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1B1—breast cancer	2.66e-06	3.55e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—STK11—breast cancer	2.65e-06	3.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP19A1—breast cancer	2.65e-06	3.54e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.61e-06	3.48e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA1—breast cancer	2.53e-06	3.38e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—STK11—breast cancer	2.5e-06	3.33e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.5e-06	3.33e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COMT—breast cancer	2.46e-06	3.29e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—breast cancer	2.45e-06	3.27e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMOX1—breast cancer	2.42e-06	3.23e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ITPR1—breast cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COMT—breast cancer	2.32e-06	3.1e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—breast cancer	2.31e-06	3.08e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TYMS—breast cancer	2.28e-06	3.04e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMOX1—breast cancer	2.28e-06	3.04e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ITPR1—breast cancer	2.27e-06	3.04e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—breast cancer	2.25e-06	3.01e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOR1—breast cancer	2.25e-06	3.01e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLA2G4A—breast cancer	2.25e-06	3.01e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—breast cancer	2.19e-06	2.92e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX1—breast cancer	2.16e-06	2.88e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TYMS—breast cancer	2.15e-06	2.87e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A1—breast cancer	2.14e-06	2.85e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—breast cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOR1—breast cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ERCC2—breast cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX1—breast cancer	2.03e-06	2.71e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.01e-06	2.69e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ERCC2—breast cancer	2e-06	2.66e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—breast cancer	1.99e-06	2.66e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—breast cancer	1.88e-06	2.51e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CAV1—breast cancer	1.84e-06	2.45e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CAV1—breast cancer	1.73e-06	2.31e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—breast cancer	1.67e-06	2.23e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.58e-06	2.1e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—breast cancer	1.47e-06	1.96e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—breast cancer	1.45e-06	1.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NOS3—breast cancer	1.39e-06	1.85e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.39e-06	1.85e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—breast cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NOS3—breast cancer	1.31e-06	1.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—breast cancer	1.28e-06	1.71e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—breast cancer	1.27e-06	1.7e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.21e-06	1.61e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—breast cancer	1.2e-06	1.6e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—breast cancer	1.11e-06	1.48e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—breast cancer	1.04e-06	1.39e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—breast cancer	7.82e-07	1.04e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—breast cancer	7.37e-07	9.83e-06	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—breast cancer	6.39e-07	8.52e-06	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—breast cancer	6.02e-07	8.03e-06	CbGpPWpGaD
